IN2014DN06475A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN06475A IN2014DN06475A IN6475DEN2014A IN2014DN06475A IN 2014DN06475 A IN2014DN06475 A IN 2014DN06475A IN 6475DEN2014 A IN6475DEN2014 A IN 6475DEN2014A IN 2014DN06475 A IN2014DN06475 A IN 2014DN06475A
- Authority
- IN
- India
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70517—CD8
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261602150P | 2012-02-23 | 2012-02-23 | |
| PCT/EP2013/053650 WO2013124474A2 (en) | 2012-02-23 | 2013-02-25 | Chromatographic isolation of cells and other complex biological materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06475A true IN2014DN06475A (ru) | 2015-06-12 |
Family
ID=47891608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6475DEN2014 IN2014DN06475A (ru) | 2012-02-23 | 2014-08-01 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10228312B2 (ru) |
| EP (1) | EP2817625A2 (ru) |
| JP (4) | JP6362543B2 (ru) |
| CN (2) | CN106940268B (ru) |
| AU (3) | AU2013224027B2 (ru) |
| CA (1) | CA2865033C (ru) |
| HK (1) | HK1202335A1 (ru) |
| IN (1) | IN2014DN06475A (ru) |
| RU (1) | RU2746407C1 (ru) |
| SG (2) | SG10201606970UA (ru) |
| WO (1) | WO2013124474A2 (ru) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9637719B2 (en) | 2013-12-06 | 2017-05-02 | Douglas T. Gjerde | Devices and methods for purification of biological cells |
| CN106940268B (zh) * | 2012-02-23 | 2021-09-21 | 朱诺治疗有限公司 | 细胞和其它复杂生物材料的色谱分离 |
| SG10201804439PA (en) | 2013-12-20 | 2018-06-28 | Hutchinson Fred Cancer Res | Tagged chimeric effector molecules and receptors thereof |
| GB2587768B (en) * | 2014-04-03 | 2021-08-18 | T Gjerde Douglas | Devices and methods for purification, detection and use of biological cells |
| CN116656605A (zh) * | 2014-04-16 | 2023-08-29 | 朱诺治疗有限公司 | 用于扩增细胞群的方法、试剂盒及装置 |
| KR20220136455A (ko) * | 2014-04-23 | 2022-10-07 | 주노 쎄러퓨티크스 인코퍼레이티드 | 입양 치료용 면역 세포 집단의 단리, 배양 및 유전자 조작 방법 |
| CN106662584B (zh) * | 2014-04-30 | 2020-05-05 | Iba股份有限公司 | 分离靶细胞的方法 |
| EP2955521A1 (en) * | 2014-06-11 | 2015-12-16 | Centre Hospitalier Universitaire Vaudois (CHUV) | Methods for separating cells |
| AU2015343121B2 (en) * | 2014-11-05 | 2020-06-18 | Juno Therapeutics, Inc. | Methods for transduction and cell processing |
| DE202014105965U1 (de) | 2014-12-10 | 2015-01-26 | Cell.Copedia GmbH | Spritzengehäuse zum Pipettieren eines biologischen Materials mit integrierten Membranen |
| WO2016166568A1 (en) | 2015-04-16 | 2016-10-20 | Juno Therapeutics Gmbh | Methods, kits and apparatus for expanding a population of cells |
| EP3288570A4 (en) | 2015-04-29 | 2018-11-21 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
| CN105606815A (zh) * | 2015-05-18 | 2016-05-25 | 烟台载通生物技术有限公司 | 一种用于免疫检测的多单元装置 |
| MA45488A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés, kits et appareil de culture de cellules |
| RU2021134624A (ru) * | 2015-10-22 | 2022-03-15 | Джуно Терапьютикс Гмбх | Способы, наборы, средства и устройства для трансдукции |
| MA45489A (fr) * | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
| GB201521784D0 (en) * | 2015-12-10 | 2016-01-27 | Univ Birmingham | Cell purification |
| JP7062640B2 (ja) | 2016-07-29 | 2022-05-06 | ジュノー セラピューティクス インコーポレイテッド | 抗ｃｄ１９抗体に対する抗イディオタイプ抗体 |
| US10294454B2 (en) | 2016-08-24 | 2019-05-21 | General Electric Company | Methods and kits for cell activation |
| AU2017381410A1 (en) * | 2016-12-23 | 2019-08-08 | Exopharm Limited | Methods and compositions for purification or isolation of microvesicles and exosomes |
| CA3050085A1 (en) | 2017-01-20 | 2018-07-26 | Juno Therapeutics Gmbh | Cell surface conjugates and related cell compositions and methods |
| CA3060526A1 (en) * | 2017-04-27 | 2018-11-01 | Juno Therapeutics Gmbh | Oligomeric particle reagents and methods of use thereof |
| JP7337773B2 (ja) | 2017-07-29 | 2023-09-04 | ジュノー セラピューティクス インコーポレイテッド | 組換え受容体を発現している細胞を増大させるための試薬 |
| WO2019032927A1 (en) | 2017-08-09 | 2019-02-14 | Juno Therapeutics, Inc. | METHODS FOR PRODUCING GENETICALLY MODIFIED CELL COMPOSITIONS AND COMPOSITIONS THEREOF |
| SG11202005272SA (en) | 2017-12-08 | 2020-07-29 | Juno Therapeutics Inc | Process for producing a composition of engineered t cells |
| EP3731947B1 (en) * | 2017-12-29 | 2023-03-01 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Purification and labeling of extracellular vesicles using a mixed mode resin composition |
| WO2020018578A1 (en) * | 2018-07-17 | 2020-01-23 | University Of Washington | Compositions and methods related to aptamer-based reversible cell selection |
| BR112021002390A2 (pt) | 2018-08-09 | 2021-05-11 | Juno Therapeutics Inc | processos para gerar células modificadas e suas composições |
| EP3850366A1 (en) | 2018-09-11 | 2021-07-21 | Juno Therapeutics, Inc. | Methods for mass spectrometry analysis of engineered cell compositions |
| BR112021008133A2 (pt) | 2018-10-31 | 2021-10-05 | Juno Therapeutics Gmbh | Métodos para seleção e estimulação de células e aparelhos para os mesmos |
| US20210393691A1 (en) | 2018-11-06 | 2021-12-23 | Juno Therapeutics, Inc. | Process for producing genetically engineered t cells |
| AU2020287882A1 (en) | 2019-06-07 | 2022-01-20 | Juno Therapeutics, Inc. | Automated T cell culture |
| EP4022637A2 (en) | 2019-08-30 | 2022-07-06 | Juno Therapeutics, Inc. | Machine learning methods for classifying cells |
| AU2020337450A1 (en) * | 2019-08-30 | 2022-03-03 | Flodesign Sonics, Inc. | Acoustic affinity cell selection for multiple target receptors |
| JP2023500318A (ja) | 2019-10-30 | 2023-01-05 | ジュノ セラピューティクス ゲーエムベーハー | 細胞選択および／または細胞刺激デバイスならびに使用方法 |
| WO2021118873A1 (en) * | 2019-12-09 | 2021-06-17 | St. Jude Children's Research Hospital, Inc. | Method for preparing cd7-negative, cd3-positive t cells |
| WO2021154887A1 (en) | 2020-01-28 | 2021-08-05 | Juno Therapeutics, Inc. | Methods for t cell transduction |
| JP2023509802A (ja) * | 2020-01-31 | 2023-03-09 | セル．コペディア ゲーエムベーハー | 生物学的実体を単離する方法 |
| KR20220152227A (ko) | 2020-02-12 | 2022-11-15 | 주노 쎄러퓨티크스 인코퍼레이티드 | Ｂｃｍａ-지시된 키메라 항원 수용체 ｔ 세포 조성물 및 이의 방법 및 용도 |
| JP2023519098A (ja) | 2020-02-12 | 2023-05-10 | ジュノー セラピューティクス インコーポレイテッド | Ｃｄ１９指向性キメラ抗原受容体ｔ細胞組成物ならびにその方法および使用 |
| WO2021231661A2 (en) | 2020-05-13 | 2021-11-18 | Juno Therapeutics, Inc. | Process for producing donor-batched cells expressing a recombinant receptor |
| JP2024517863A (ja) | 2021-05-06 | 2024-04-23 | ジュノ・セラピューティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 細胞を刺激し、形質導入する方法 |
| WO2023017115A1 (en) * | 2021-08-11 | 2023-02-16 | Iba Lifesciences Gmbh | Fractionation of cells based on a marker protein |
| CN113908589B (zh) * | 2021-10-08 | 2022-09-27 | 天津工业大学 | 一种表面印迹抗体的疏水电荷诱导模式膜层析介质及其制备方法 |
| WO2023147510A1 (en) | 2022-01-28 | 2023-08-03 | Juno Therapeutics, Inc. | Chromatography arrays and related methods and kits |
| EP4223381A1 (en) * | 2022-02-02 | 2023-08-09 | Sartorius BIA Separations d.o.o. | Method of purifying or removing a target component from full plasma |
| WO2023213969A1 (en) | 2022-05-05 | 2023-11-09 | Juno Therapeutics Gmbh | Viral-binding protein and related reagents, articles, and methods of use |
| WO2023230581A1 (en) | 2022-05-25 | 2023-11-30 | Celgene Corporation | Methods of manufacturing t cell therapies |
| WO2024100604A1 (en) | 2022-11-09 | 2024-05-16 | Juno Therapeutics Gmbh | Methods for manufacturing engineered immune cells |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986002077A1 (en) | 1984-10-02 | 1986-04-10 | Meade Harry M | Production of streptavidin-like polypeptides |
| US4851341A (en) | 1986-12-19 | 1989-07-25 | Immunex Corporation | Immunoaffinity purification system |
| DE4237113B4 (de) | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
| AU5132096A (en) | 1995-01-30 | 1996-08-21 | Terrapin Technologies, Inc. | Glubodies - multiplicities of proteins capable of binding a variety of small molecules |
| JPH11501008A (ja) | 1995-02-09 | 1999-01-26 | ユニバーシティ オブ ワシントン | 改変−アフィニティーストレプトアビジン |
| WO1997011183A1 (en) | 1995-04-11 | 1997-03-27 | Trustees Of Boston University | Streptavidin mutants |
| DE19641876B4 (de) | 1996-10-10 | 2011-09-29 | Iba Gmbh | Streptavidinmuteine |
| CA2283716A1 (en) | 1997-03-14 | 1998-09-17 | Gabriel O. Reznik | Multiflavor streptavidin |
| US5985658A (en) | 1997-11-14 | 1999-11-16 | Health Research Incorporated | Calmodulin-based cell separation technique |
| DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
| EP1227321A1 (en) | 2000-12-28 | 2002-07-31 | Institut für Bioanalytik GmbH | Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| DE10113776B4 (de) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins |
| WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| ATE370159T1 (de) * | 2002-03-01 | 2007-09-15 | Volker A Erdmann | Streptavidin-bindungspeptid |
| US7754155B2 (en) * | 2002-03-15 | 2010-07-13 | Ross Amelia A | Devices and methods for isolating target cells |
| FR2841905B1 (fr) | 2002-07-05 | 2004-09-03 | Centre Nat Rech Scient | Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications |
| EP1690090A1 (en) * | 2003-11-20 | 2006-08-16 | Biosensor Applications Sweden AB (Publ) | Mixture of at least two different antibodies specific for predetermined antigens and use of the mixture |
| DE602005013957D1 (de) * | 2004-06-03 | 2009-05-28 | Meso Scale Technologies Llc | Verfahren zur durchführung von vollbluttests |
| GB0422431D0 (en) * | 2004-10-08 | 2004-11-10 | Affitech As | Method |
| JP5255841B2 (ja) * | 2004-10-15 | 2013-08-07 | ジェネンコー・インターナショナル・インク | 競合示差スクリーニング |
| US20060252087A1 (en) * | 2005-01-18 | 2006-11-09 | Biocept, Inc. | Recovery of rare cells using a microchannel apparatus with patterned posts |
| US7855057B2 (en) * | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
| WO2008053973A1 (en) * | 2006-11-02 | 2008-05-08 | Kyowa Medex Co., Ltd. | Method of immunoassay of component to be measured |
| AU2007353319A1 (en) | 2006-11-15 | 2008-11-20 | Invitrogen Dynal As | Methods for reversibly binding a biotin compound to a support |
| CN101226118B (zh) * | 2007-01-19 | 2010-06-16 | 中国医学科学院肿瘤研究所 | 一种兼容免疫荧光分析的细胞化学染色方法及其用途 |
| JP4962215B2 (ja) | 2007-08-28 | 2012-06-27 | パナソニック株式会社 | 墨出し器の精度確認装置及び墨出し器の精度確認方法 |
| EP3358354B1 (en) * | 2008-01-18 | 2020-07-15 | President and Fellows of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| ES2890729T3 (es) | 2008-01-29 | 2022-01-21 | Hutchinson Fred Cancer Res | Identificación de células T CD8+ que son CD161hi y/o IL-18Rahi y que tienen una capacidad de evacuación rápida de fármacos |
| EP2363501A1 (en) | 2010-03-02 | 2011-09-07 | Universitätsklinikum Hamburg-Eppendorf | Method for isolating target cells |
| EP3376225A1 (en) * | 2010-08-06 | 2018-09-19 | Ludwig-Maximilians-Universität München | Identification of t cell target antigens |
| CN103797028B (zh) | 2011-07-18 | 2017-08-25 | Iba 股份有限公司 | 使靶细胞可逆染色的方法 |
| CN106940268B (zh) | 2012-02-23 | 2021-09-21 | 朱诺治疗有限公司 | 细胞和其它复杂生物材料的色谱分离 |
| CN116656605A (zh) | 2014-04-16 | 2023-08-29 | 朱诺治疗有限公司 | 用于扩增细胞群的方法、试剂盒及装置 |
| MA45488A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés, kits et appareil de culture de cellules |
| RU2021134624A (ru) | 2015-10-22 | 2022-03-15 | Джуно Терапьютикс Гмбх | Способы, наборы, средства и устройства для трансдукции |
| MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
-
2013
- 2013-02-25 CN CN201710137379.4A patent/CN106940268B/zh active Active
- 2013-02-25 JP JP2014558137A patent/JP6362543B2/ja active Active
- 2013-02-25 CA CA2865033A patent/CA2865033C/en active Active
- 2013-02-25 SG SG10201606970UA patent/SG10201606970UA/en unknown
- 2013-02-25 EP EP13709791.1A patent/EP2817625A2/en active Pending
- 2013-02-25 AU AU2013224027A patent/AU2013224027B2/en active Active
- 2013-02-25 WO PCT/EP2013/053650 patent/WO2013124474A2/en active Application Filing
- 2013-02-25 SG SG11201404991YA patent/SG11201404991YA/en unknown
- 2013-02-25 CN CN201380010911.6A patent/CN104254780B/zh active Active
- 2013-02-25 RU RU2014138172A patent/RU2746407C1/ru active
- 2013-02-25 US US14/380,699 patent/US10228312B2/en active Active
-
2014
- 2014-08-01 IN IN6475DEN2014 patent/IN2014DN06475A/en unknown
-
2015
- 2015-03-20 HK HK15102849.2A patent/HK1202335A1/xx unknown
-
2018
- 2018-02-28 JP JP2018034273A patent/JP6857626B2/ja active Active
- 2018-12-21 US US16/231,193 patent/US20190234844A1/en active Pending
- 2018-12-21 US US16/231,188 patent/US20190226951A1/en active Pending
-
2019
- 2019-01-11 AU AU2019200178A patent/AU2019200178B2/en active Active
-
2021
- 2021-03-22 JP JP2021046729A patent/JP7192014B2/ja active Active
- 2021-12-08 AU AU2021282451A patent/AU2021282451A1/en active Pending
-
2022
- 2022-12-07 JP JP2022195658A patent/JP2023016981A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104254780B (zh) | 2017-04-12 |
| JP2018108103A (ja) | 2018-07-12 |
| AU2013224027B2 (en) | 2019-01-24 |
| CN104254780A (zh) | 2014-12-31 |
| JP6857626B2 (ja) | 2021-04-14 |
| AU2021282451A1 (en) | 2022-01-06 |
| AU2019200178B2 (en) | 2021-09-09 |
| JP6362543B2 (ja) | 2018-07-25 |
| US10228312B2 (en) | 2019-03-12 |
| US20190234844A1 (en) | 2019-08-01 |
| SG10201606970UA (en) | 2016-10-28 |
| JP7192014B2 (ja) | 2022-12-19 |
| JP2021090471A (ja) | 2021-06-17 |
| US20150024411A1 (en) | 2015-01-22 |
| CA2865033C (en) | 2021-11-02 |
| EP2817625A2 (en) | 2014-12-31 |
| CA2865033A1 (en) | 2013-08-29 |
| WO2013124474A2 (en) | 2013-08-29 |
| JP2015512621A (ja) | 2015-04-30 |
| JP2023016981A (ja) | 2023-02-02 |
| AU2019200178A1 (en) | 2019-01-31 |
| HK1202335A1 (en) | 2015-09-25 |
| AU2013224027A1 (en) | 2014-10-02 |
| CN106940268A (zh) | 2017-07-11 |
| US20190226951A1 (en) | 2019-07-25 |
| WO2013124474A3 (en) | 2013-12-05 |
| SG11201404991YA (en) | 2014-09-26 |
| CN106940268B (zh) | 2021-09-21 |
| RU2746407C1 (ru) | 2021-04-13 |